守护国民眼健康！进博舞台见证创新，多元举措赋能视觉管理

Core Insights - Eye health is a crucial component of national health, affecting all age groups and significantly impacting quality of life and social burdens [1] - The "14th Five-Year Plan" emphasizes the prevention and treatment of myopia and cataracts, aiming for comprehensive coverage of cataract surgery capabilities by the end of 2027 [1] - The demand for eye health services is shifting from treatment to prevention and improved service quality, driven by economic development and an aging population [1] Group 1: Policy and Planning - The National Health Commission has identified eye diseases, particularly retinal diseases, as key areas for prevention and management, focusing on early screening and long-term care for the elderly [2] - The burden of neovascular age-related macular degeneration (nAMD) is expected to rise significantly, with the number of patients projected to increase from 4.5 million in 2020 to 8.8 million by 2050 [2] - If not addressed, approximately 75.7% of nAMD patients may progress to legal blindness within three years, highlighting the urgent need for effective interventions [2] Group 2: Innovation in Treatment - Bayer's Eylea 8mg has been launched nationwide, offering a more effective treatment option for nAMD patients with longer intervals between injections, potentially improving treatment adherence and quality of life [2][3] - Clinical trials have shown that Eylea 8mg can achieve similar vision improvement with fewer injections compared to the 2mg dosage, thus reducing the treatment burden on patients [3] - The drug's ability to decrease injection frequency addresses both patient and healthcare provider concerns, facilitating better long-term management of nAMD [3] Group 3: Comprehensive Eye Health Solutions - A comprehensive visual health protection system is essential for safeguarding national eye health, with initiatives targeting all demographics and life stages [5] - EssilorLuxottica has introduced new products for myopia management and adult visual health, alongside collaborations to enhance consumer insights and industry standards [5] - The "National Visual Health Report (2026 Edition)" is being developed to further address myopia prevention and expand into comprehensive eye health strategies [5] Group 4: Cross-Industry Innovations - EssilorLuxottica is also venturing into hearing health, addressing the significant market gap for hearing aids, with an estimated 1.25 billion people globally suffering from mild to moderate hearing loss [6] - The Nuance Audio hearing glasses, which integrate advanced hearing technology into stylish eyewear, have been launched to cater to individuals with hearing impairments [6][7] - Following FDA and CE certifications, the Nuance Audio product is set for accelerated introduction into global markets, including China, to benefit a larger user base [7]